Search Results

Displaying Results 501-525 of 546 "'BIOS'"

Oct 15, 2025, 08:05 ET Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

time-to-patient. The partnership combines Avantor's bioprocessing and custom ancillary-reagent manufacturing capabilities with BlueWhale Bio's Synecta™ cell-derived nanoparticle (CDNP) platform, which mimics natural T-cell stimulation. The collaboration aims to accelerate CDNP manufacturing

More news about: Avantor and Financial News


Oct 15, 2025, 08:00 ET Monod Bio Receives Award to Develop a New Diagnostic Test for Preeclampsia using AI-designed Proteins

preeclampsia, sFlt-1 and PlGF. The new diagnostic will be built on Monod Bio's proprietary NovoLISA™ platform, which combines two cutting-edge technologies: NovoBody™ binders and LuxSit™. "Monod Bio's NovoBody™ Binders represent a new class of computationally

More news about: Monod Bio


Oct 14, 2025, 08:21 ET Immorta Bio Publishes in Prestigious Academic Journal Patent-Pending Approach to "Re-Awakening" Coma Patients

Health, presents a new hypothesis for restoring consciousness in coma patients. The proposed approach combines two of Immorta Bio's complementary technologies — first, using SenoVax™, a senolytic immunotherapy, to eliminate toxic senescent cells to reduce neuroinflammation, which

More news about: Immorta Bio, Inc.


Oct 13, 2025, 10:25 ET GTCR Announces Promotions and New Team Appointments Across the Organization

strategically, and in the competitive marketplace." GTCR Investment Professional and PRG Team Member Bios Ryan Beauchamp, Managing DirectorRyan joined GTCR in 2025 to lead AI and

More news about: GTCR


Oct 13, 2025, 07:00 ET Discover how Developments in Technology and Preventative Solutions are Driving Change

Revalia Bio's platform enables Human Data Trials that accelerate drug development before the first clinical trial begins, helping to eliminate patient risk, while

More news about: Advancements


Oct 09, 2025, 10:00 ET Adaptiva Wins 2025 CyberSecurity Breakthrough Award for Patch Management Solution of the Year for the Second Year in a Row

autonomous, end-to-end approach to vulnerability remediation, and for continuously identifying, deploying, and verifying patches across Windows, Mac, Linux, BIOS, drivers, and over 20,000 third-party applications. "We built OneSite Patch to redefine what enterprises should expect from patch

More news about: Adaptiva


Oct 09, 2025, 10:00 ET Sharp Launches 18 New Workgroup MFPs for Smarter Productivity

intelligent self-healing features that help ensure maximum performance and uptime. Sharp has also raised the bar on security, incorporating enhanced BIOS Integrity Check with backup recovery and a new End-of-Lease data erase method that is compliant with NIST SP800-88 standards. Productivity

More news about: Sharp Imaging and Information Company of America (SIICA)


Oct 09, 2025, 09:15 ET FALL AT THE LOOP

December 19 – Man in the Mirror: A Tribute to Michael Jackson For band bios and performance details, visit The LOOP's newsroom at

More news about: The LOOP, Fort Lauderdale Beach


Oct 09, 2025, 07:52 ET Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models

reducing inflammation, few address the critical need for myelin repair or provide meaningful recovery. New preclinical results demonstrate that Cadenza Bio's lead compounds, K102 and K110, deliver dual benefits, enhancing remyelination and modulating immune activity, with functional recovery observed in visual

More news about: Cadenza Bio, Inc.


Oct 06, 2025, 10:23 ET Made Scientific and Streamline Bio Announce Collaboration to Accelerate AI-Driven Robotic Manufacturing for Cell Therapies

Streamline Bio's fully AI-driven platform addresses critical and bottlenecks in the CGT industry – including manufacturing complexity and the high cost and variable quality of cell therapies. Unlike rigid, infrastructure-heavy siloed robotic automation solutions, Streamline Bio's innovative

More news about: Made Scientific, Inc.


Oct 06, 2025, 09:01 ET Surf Bio to Participate in the 5th Annual Needham Private Biotech and MedTech Company Virtual 1×1 Forum

During the conference, Mr. Mazlish will conduct one-on-one meetings with registered investors, showcasing Surf Bio's business and development strategy, including advancements with its proprietary SnapShot™ technology platform. SnapShot is designed to enable subcutaneous

More news about: Surf Bio, Inc.


Oct 03, 2025, 11:14 ET FDA Grants RMAT Designation to Avobis Bio's Implantable Cell Therapy AVB-114 for Crohn's Perianal Fistulas

Results from the phase II primary analysis are the latest milestone in Avobis Bio's implantable cell therapy pipeline and provide new data to share in ongoing fundraising activities.  "We are encouraged by the

More news about: Avobis Bio


Oct 03, 2025, 11:09 ET Solarea Bio Appoints New Chief Executive Officer

Catherine Balsam-Schwaber Will Bring Track Record of Scaling Mission-Driven Health Companies to Solarea Bio's Breakthrough Solutions for Healthy Aging Commercial Launch of Bondia™,

More news about: Solarea Bio


Oct 02, 2025, 17:31 ET Graves' Orbitopathy Market to Exhibit Growth at a CAGR of 19.8% During the Forecast Period (2025-2034) | DelveInsight

VRDN-003, argenx's efgartigimod PH20 SC, Immunovant Sciences/HanAll Biopharma/Samsung Biologics's batoclimab, Sling Therapeutics' Linsitinib, Tourmaline Bio's Pacibekitug, and others, showing promise as disease-modifying, steroid-sparing therapies to improve outcomes in moderate-to-severe TED.

More news about: DelveInsight Business Research, LLP


Oct 02, 2025, 12:00 ET Endevica Bio Unveils Differentiated Mechanism for Durable Weight Loss in Obesity

activation of MC3R and MC4R may be the key to unlocking superior weight loss efficacy compared to MC4R agonism alone. Endevica Bio's orally available, dual-MC3/4R agonist 710GO demonstrates the following in obese nonhuman primates:

More news about: Endevica Bio


Oct 02, 2025, 06:00 ET 4Way Foods Launches UK's New Online Supermarket for British & World Foods - With Plans to Use AI to Reshape Grocery Shopping

Interview Requests & Assets View our full press kit (product images, founder bios, and brand assets): Press

More news about: 4Way Foods


Oct 01, 2025, 13:37 ET Wheeler Bio Appoints Jay Benson as Chief Operating Officer

providing agile, domestic biologics manufacturing capacity for biotechnology innovators. As the demand for U.S. based biomanufacturing increases, Wheeler Bio's ModularCMC™ platform is well positioned to streamline the path from discovery to clinical development for antibody-based therapeutics, with maximum

More news about: Wheeler Bio, Inc.


Oct 01, 2025, 09:00 ET ASUS Data revels US SMBs are Underestimating Cyber Risks

ASUS' newest ExpertBook P3 enables professionals to stay productive and protected through ExpertGuardian, a NIST SP 800-155 compliant BIOS and Windows 11 Secured-core technologies. The

More news about: ASUS Computer International


Oct 01, 2025, 08:53 ET Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein Cargo to the Brain

accumulating in the cytoplasm of neurons throughout the brain." About the yEV™ platform:Mercury Bio's yEV™ platform utilizes yeast-derived exosomes, a subtype of extracellular vesicle (EV). EVs are nanoparticles, produced by cells, that facilitate intercellular

More news about: Mercury Bio Inc.


Oct 01, 2025, 08:00 ET Monod Bio Announces Appointment of Timothy I. Still as Executive Chairman

appointments, his background brings financial, commercial and business development leadership and expertise to Monod Bio. "Monod Bio's de novo protein design platform has the potential to fundamentally change diagnostics and research markets," said Mr. Still. "The company has a truly

More news about: Monod Bio


Oct 01, 2025, 03:00 ET CJ BIO Introduces Cost-Effective Solutions to Elevate Meat Quality in Europe

better yield and taste while reducing additives are emerging as the best value propositions in the B2B meat sector (FoodIngredientsFirst, 2024). CJ BIO's TasteNrich® portfolio addresses these exact needs, providing performance-driven, cost-effective solutions that meet Europe's evolving regulatory

More news about: CJ BIO


Sep 29, 2025, 23:57 ET Redress x United Nations Fashion and Lifestyle Network: Global Call for Fashion to Deliver on the SDGs

here.Link to the three designers' bios here.

More news about: Redress


Sep 29, 2025, 23:39 ET Redress x United Nations Fashion and Lifestyle Network: Global Call for Fashion to Deliver on the SDGs

here.Link to the three designers' bios here.

More news about: Redress


Sep 29, 2025, 06:00 ET AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress

ROC-101's mechanism of action is complementary to other disease-modifying therapies in the pulmonary hypertension space. AllRock Bio's Phase 2a ROCSTAR clinical trial will evaluate ROC-101 in combination with standard of care in PAH and ILD-PH patients and is expected to initiate in

More news about: AllRock Bio


Sep 26, 2025, 09:00 ET Pivot Bio Evolving World-Class Digital Strategy

experience leading global engineering, data and product organizations across agriculture and technology, and will play a key role in advancing Pivot Bio's digital capabilities to better support growers and optimize on-farm agronomic performance.

More news about: Pivot Bio, Inc


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.